Skip to content

Comparison between two Hyaluronic Acid protocols for the treatment of TMJ Arthrosis.

Therapeutical efficacy of two clinical protocols for Viscosuplementation of Temporomandibular joint in patients with Osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2nywjd
Enrollment
Unknown
Registered
2020-09-01
Start date
2018-08-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

This study will compare two treatment protocols for hyaluronic acid injections in the temporomandibular joint. Participants will be divided into 2 groups: Group A: 11 subject will receive 3 hyaluroni
Drug
Procedure/surgery

Sponsors

Faculdade de Odontologia Universidade Federal do Rio de Janeiro
Lead Sponsor
Faculdade de Odontologia Universidade Federal do Rio de Janeiro
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: It will be included individuals of both genders, literacy, over 18 years, presenting at least one of the following symptoms: unilateral or bilateral TMJ pain, occurring spontaneously and/or during mandibular function; presenting joint noises: crepitation or click, unilateral or bilateral; mouth opening limitation and articular pain during palpation of the TMJ, either unilateral or bilateral. All study subjects must meet the criteria of group III of the Research Diagnostic Criteria for Temporomandibular Disorders (RDC-TMD). Each individual should have a CT scan showing one or more of the following changes: joint erosion, proven by loss of normal cortical bone design; sclerosis of parts or all of the condyle and/or joint eminence; flattening of joint surfaces; presence of osteophyte; presence of subchondral cysts.

Exclusion criteria

Exclusion criteria: Individuals who do not meet the inclusion criteria; history of TMJ surgery; volunteers with impaired verbal communication due to neurological disorder, previous disease sequelae or psychiatric condition; pregnant women; individuals taking osteoarthritis modifying medications such as condoitine, glucosamine or diacerin; illiterate individuals

Design outcomes

Primary

MeasureTime frame
It is expected to evaluate the maximum mouth opening by measuring in millimeters the distance between the incisal edge of the upper and lower central incisors with the subject in the largest voluntary mouth opening.;it is expected to evaluate the pain measured by visual analog scale.

Secondary

MeasureTime frame
It is expected to evaluate mouth opening by passive stretching which consists of measuring in millimeters the distance between the incisal edge of the upper and lower central incisors with the subject in the largest forced mouth opening.;Functional limitation measured by visual analog scale;It is expected to evaluate theTreatment tolerance measured by visual analog scale

Countries

Brazil

Contacts

Public ContactNatália ;Natália Ferreira;Ferreira

Faculdade de Odontologia Universidade Federal do Rio de Janeiro;Universidade Federal do Rio de Janeiro

natalia_ferreira@ufrj.br;natrferreira@gmail.com0055213938-2033;24 981076200

Outcome results

None listed

Source: REBEC (via WHO ICTRP)